<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957772</url>
  </required_header>
  <id_info>
    <org_study_id>2019 SUPRA</org_study_id>
    <nct_id>NCT03957772</nct_id>
  </id_info>
  <brief_title>The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block</brief_title>
  <acronym>SUPRA</acronym>
  <official_title>The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block: a Randomized Controlled, Single-blinded Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital du Valais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hôpital du Valais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be randomized to one of two groups:&#xD;
&#xD;
        1. Extrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block&#xD;
           with 2 injections of local anaesthetic, deposited at the exterior of the fascial sheath&#xD;
           that surrounds the nerves&#xD;
&#xD;
        2. Intrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block&#xD;
           with 2 injections of local anaesthetic, deposited at the interior of the fascial sheath&#xD;
           that surrounds the nerves&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be proposed to all patients undergoing formarm or hand surgery under axillary&#xD;
      brachial plexus block. Patients will be randomized to one of two groups.&#xD;
&#xD;
      The first group - extrafascial injection group - will receive an ultrasound-guided&#xD;
      supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the&#xD;
      exterior of the fascial sheath that surrounds the nerves.&#xD;
&#xD;
      The second group - intrafascial injection group - will receive an ultrasound-guided&#xD;
      supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the&#xD;
      interior of the fascial sheath that surrounds the nerves.&#xD;
&#xD;
      All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of&#xD;
      ropivacaine 0.5 % + mepivacaine 1 %.&#xD;
&#xD;
      The primary outcome is the rate of hemidiaphragmatic paresis 30 minutes after the block&#xD;
      procedure, assessed with ultrasound. Secondary outcomes are: rate of hemidiaphragmatic&#xD;
      paresis 2 hours after surgery, assessed with ultrasound, bedside spirometry before the&#xD;
      supraclavicular block, 30 minutes after the block and 2 hours after surgery, rate of&#xD;
      successful block 30 minutes after the block , duration of sensory and motor block, pain&#xD;
      scores at rest and on movement at 24 h postoperatively, cumulative postoperative opioid&#xD;
      consumption at 24 hours postoperatively and patient satisfaction with overall anesthetic&#xD;
      management.&#xD;
&#xD;
      These outcomes are further defined in the section below.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The participants and all care providers will be blinded to the patient assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hemidiaphragmatic paresis 30 minutes after the block</measure>
    <time_frame>30 minutes after the block</time_frame>
    <description>Rate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemidiaphragmatic paresis 2 hours after surgery</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Rate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bedside spirometry before the block (baseline)</measure>
    <time_frame>30 minutes before the block</time_frame>
    <description>Bedside spirometry before the supraclavicular block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bedside spirometry after 30 minutes after the block</measure>
    <time_frame>30 minutes after the supraclavicular block</time_frame>
    <description>Bedside spirometry after the supraclavicular block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bedside spirometry 2 hours after surgery</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Bedside spirometry 2 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of successful block 30 minutes after the block</measure>
    <time_frame>30 minutes after the block</time_frame>
    <description>Presence of a surgical block according to a validated composite scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block-related side effects</measure>
    <time_frame>24 h postoperatively</time_frame>
    <description>paresthesia, dyspnea, Horner's syndrome, hoarseness, hematoma, infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during block procedure</measure>
    <time_frame>During block procedure</time_frame>
    <description>Pain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at rest and on movement</measure>
    <time_frame>24 h postoperatively</time_frame>
    <description>Pain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Cumulative postoperative opioid consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with overall anesthetic management</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>numeric rating scale, 0-10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Upper Extremity Problem</condition>
  <arm_group>
    <arm_group_label>Extrafascial injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extrafascial injection of local anesthetic&#xD;
Ultrasound guided supraclavicular plexus block with extrafascial injection of local anesthetic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrafascial injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intrafascial injection of local anesthetic&#xD;
Ultrasound guided supraclavicular plexus block with intrafascial injection of local anesthetic</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extrafascial injection</intervention_name>
    <description>Extrafascial injection of local anaesthetic under ultrasound guidance</description>
    <arm_group_label>Extrafascial injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrafascial injection</intervention_name>
    <description>Intrafascial injection of local anaesthetic under ultrasound guidance</description>
    <arm_group_label>Intrafascial injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing forearm or hand surgery under locoregional anesthesia&#xD;
&#xD;
          -  ASA physical status I-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  ASA physical status IV&#xD;
&#xD;
          -  Severe pre-existing lung disease&#xD;
&#xD;
          -  Patient unwilling or unable to perform incentive spirometry&#xD;
&#xD;
          -  Local anesthetic intolerance or allergy&#xD;
&#xD;
          -  Neurological deficit or neuropathy of the arm&#xD;
&#xD;
          -  Coagulopathy contraindicating locoregional anesthesia&#xD;
&#xD;
          -  Malignancy or infection in the area above the clavicle&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability to understand the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sina Grape, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital du Valais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital du Valais</name>
      <address>
        <city>Sion</city>
        <zip>1950</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>upper extremity surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no sharing of any IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

